[Present treatment of the Vaquez's disease].
D000368:Aged; D000740:Anemia / Q000150:complications; D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001782:Blood Donors; D001810:Blood Volume; D001815:Bloodletting; D002066:Busulfan / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000150:complications; D006417:Hematuria / Q000150:complications; D006801:Humans; D007953:Leukemia, Radiation-Induced; D007964:Leukocytosis / Q000150:complications; D010437:Peptic Ulcer / Q000150:complications; D010759:Phosphorus Isotopes / Q000008:administration & dosage* / Q000009:adverse effects; D010885:Pipobroman / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011183:Postoperative Complications; D013163:Splenomegaly / Q000150:complications; D013921:Thrombocytopenia / Q000139:chemically induced; D013927:Thrombosis / Q000517:prevention & control; D014652:Vascular Diseases / Q000150:complications
D000925:Anticoagulants; D000970:Antineoplastic Agents; D010759:Phosphorus Isotopes; D010885:Pipobroman; D002066:Busulfan
Traitement actuel de la maladie de Vaquez.